ArticleDrugs in context2017

Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapies.

Sabrina Rossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.